# Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.

> **NCT02956369** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 20 (actual)

## Conditions studied

- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Control
- **DIETARY_SUPPLEMENT:** SATIOSTAT

## Key facts

- **NCT ID:** NCT02956369
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-16
- **Primary completion:** 2019-05-06
- **Final completion:** 2019-05-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956369, "Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02956369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*